- Home
- FRT vs PCVX Comparison
FRT vs PCVX Comparison
Compare FRT & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRT | PCVX |
|---|---|---|
| Founded | 1962 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 6.0B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | FRT | PCVX |
|---|---|---|
| Price | $101.97 | $46.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 7 |
| Target Price | ★ $110.21 | $101.67 |
| AVG Volume (30 Days) | 691.3K | ★ 1.5M |
| Earning Date | 10-31-2025 | 11-04-2025 |
| Dividend Yield | ★ 4.46% | N/A |
| EPS Growth | ★ 14.84 | N/A |
| EPS | ★ 3.95 | N/A |
| Revenue | ★ $1,257,396,000.00 | N/A |
| Revenue This Year | $5.51 | N/A |
| Revenue Next Year | $5.27 | N/A |
| P/E Ratio | $25.69 | ★ N/A |
| Revenue Growth | ★ 6.11 | N/A |
| 52 Week Low | $80.65 | $27.66 |
| 52 Week High | $113.13 | $93.77 |
Technical Indicators
Market Signals| Indicator | FRT | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 63.79 | 54.15 |
| Support Level | $100.00 | $42.40 |
| Resistance Level | $102.81 | $45.15 |
| Average True Range (ATR) | 1.45 | 1.95 |
| MACD | 0.48 | -0.30 |
| Stochastic Oscillator | 83.12 | 68.65 |
Price Performance
Historical ComparisonAbout FRT Federal Realty Investment Trust
Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 102 properties, which includes 27.4 million square feet of retail space and 3,000 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.